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The right atrial appendage (RAA) is believed to be an unsuitable pacing site for the prevention of ATA, because it lengthens the inter-or intraatrial conduction time and increases the dispersion of atrial refractoriness. 15 Therefore, low atrial septal (LAS) pacing has been recommended instead of RAA pacing to prevent ATA, 16 though this remains to be confirmed by randomized clinical trial. 17 However, because the LAS region is closer to the ventricle than the RAA, it may be associated with a higher likelihood of FFRW oversensing, 16, 18 though the prevalence and characteristics of FFRW sensing associated with LAS pacing have not been formally studied.
We hypothesized that recipients of bipolar atrial leads with widely spaced tip-ring electrodes implanted in the LAS and who have left ventricular hypertrophy (LVH) on 12-lead ECG are at increased risk of FFRW sensing after ventricular pacing. To test this hypothesis, we measured the prevalence and examined the characteristics of FFRW sensing in recipients of dualchamber pacemakers, as well as the effects of the tip-ring 599 FFRW in LAS Pacing 
Methods

Study Protocol
The 31 patients enrolled in this study underwent implantation of dual-chamber pacemakers for bradyarrhythmias, according to published professional practice guidelines. 19 Written informed consent to participate in this study was given by all patients, and the study protocol was approved by FFRW sensing was evaluated in the supine position at 7 days after pacemaker implantation, before discharge of the patient from the hospital. The post-ventricular atrial blanking period was temporarily set to a minimum of 60 ms. The sensing of FFRW was recorded with the programmer, after full ventricular capture. The atrial sensitivity was initially programmed to 0.1 mV and increased in 0.1-mV steps. The presence of sensed P wave markers within the post-ventricular atrial refractory period of the intracardiac electrogram confirmed the sensing of FFRW ( Figure 1A) . LVH on ECG was diagnosed on the basis of the Framingham criteria, including (1) R wave in Vl >11 mm, R wave in V4-6 >25 mm, S wave in V1-3 >25 mm, S wave in V1 or V2 + R wave in V5 or V6 >35 mm, and R wave in I + S wave in III >25 mm. 20 The correlation between the presence of LVH on ECG and FFRW signals on the atrial channel was examined. The LV mass on echocardiography was calculated according to the method of Devereux et al, 21 normalized for the body surface area and reported as the LV mass index.
Implantation of the Lead in the LAS
The successful placement of the lead in the LAS was confirmed by (1) pointing of the tip of the lead posteriorly on the lateral Posterior wall thickness, mm 9.3±1.6
Interventricular septum thickness, mm 9.0±1.9
Left atrial diameter, mm 42±7
Roentgenographic cardiothoracic ratio, % 53±5
Values are ± SD or n (%) of observations. LVH, left ventricular hypertrophy. Values are ± SD or n (%) of observations. HR, hazard ratio; CI, confidence interval. Other abbreviations see in Table 2 . chest roentgenogram, and (2) a negative P wave in the inferior leads and isoelectric or negative P wave in leads I, V5 and V6 during atrial pacing, on 12-lead ECG (Figures 1B,C) . [16] [17] [18] Statistical Analysis Continuous variables are expressed as means ± standard deviation. Factors influencing the sensing of FFRW were determined using the chi-square test, and between-group comparisons were made by Mann-Whitney's U-test for continuous variables and by Fisher's exact test for dichotomous variables. Variables with P value <0.05 in the single variable analysis were entered into a multiple variable logistic regression analysis to identify independent predictors of FFRW sensing. A P value <0.05 was considered statistically significant.
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Results
Patient Characteristics
The characteristics of the 19 women and 12 men participating in this study, whose mean age was 74±10 years, are shown in Table 1 . The pacing indications were sick sinus syndrome in approximately 75% and atrioventricular (AV) block in 25% of patients. The atrial lead was implanted in the LAS without dislodgement, infection, perforation, development of pericardial effusion, or pacing or sensing failure in any patient.
Prevalence of FFRW
With the atrial bipolar sensitivity set at 0.1, 0.2, 0.3 and 0.5 mV, FFRW were sensed in 24 (77%), 13 (42%), 9 (29%), and 9 (29%) of the 31 patients, respectively (Figure 2) . Table 2 shows that, at a programmed atrial sensitivity of 0.1 mV, the 24 patients in whom FFRW was sensed and the 7 patients in whom FFRW was not sensed shared similar characteristics. However, when the atrial sensitivity was increased to 0.3 mV (Table 3) , the 9 patients in whom FFRW sensing persisted were significantly more likely to be (1) recipients of atrial leads with 10-mm tip-ring electrodes spacing (P=0.036), and (2) have LVH on 12-lead ECG (P=0.024). By multiple variable analysis, (1) LVH on ECG, and (2) a 10.0-mm tip-ring atrial electrode spacing were independent predictors of FFRW sensing ( Table 3) . Figures 3A-C shows the positive correlation between the QRS voltage measured on 12-lead ECG and the amplitude of the FFRW signals in all patients, in the recipients of atrial leads with 10-mm interelectrode spacing, and in patients who received atrial leads with 1.1 mm interelectrode spacing.
Predictors of FFRW Sensing
Correlation Between Interelectrode Spacing of the Atrial Lead and FFRW Sensing
The mean intrinsic P wave sensitivity associated with the 1.1-mm tip-ring atrial electrode spacing was 2.0±1.0 mV vs. 2.1±1.7 mV with the 10.0-mm spacing (not significant); likewise, the mean pacing thresholds associated with each interelectrode spacing (1.0±0.3 V vs. 0.8±0.2 V) were similar. In contrast, the mean 363±51 Ω lead impedance associated with the 1.1-mm was significantly lower than the 424±68 Ω associated with the 10.0-mm spacing (P=0.01). In 3 of 16 recipients of atrial leads with 1.1-mm, and 4 of 15 recipients of leads with 10.0-mm interelectrode spacing, FFRW was not sensed at an atrial sensitivity of 0.1 mV. In the remaining 24 patients in whom FFRW were sensed at an atrial sensitivity of 0.1 mV, the mean interval between the ventricular pacing stimulus and the FFRW sensed in the atrial channel was similar whether the tip-ring interelectrode spacing of the atrial lead was 1.1 mm (106±13 ms) or 10.0 mm (110±13 ms). In addition, the amplitude of FFRW sensing after both ventricular pacing and sensing (intrinsic QRS) was compared in 24 patients who had intrinsic QRS complex. The amplitude of FFRW sensing after ventricular pacing was significantly higher that that after ventricular sensing in both 10.0-mm and 1.1-mm spacing interelec- Figure 3 shows the correlation between the prevalence of FFRW sensing and atrial sensitivity setting with each tipring interelectrode spacing. The prevalence of FFRW sensing was similar with both spacings when the atrial sensitivity was <0.3 mV. However, when the programmed atrial sensitivity was ≥0.3 mV, the prevalence of FFRW sensing was significantly lower with the 1.1-mm than with the 10.0-mm tip-ring interelectrode spacing of the atrial lead (Figure 4) .
Correlation Between Presence of LVH on 12-Lead ECG and FFRW Sensing
LVH was present on the 12-lead ECG of 6 of the 31 patients (19%). With the atrial sensitivity programmed at 0.1 mV, FFRW were sensed in 6 of 6 patients (100%) with LVH vs. 18 of 25 patients (72%) without LVH (not significant; Figure 5 ). However, with the atrial sensitivity set at ≥0.3 mV, a common setting in clinical practice, FFRW were sensed in 4 of 6 patients (67%) with vs. 5 of 25 patients (20%) without LVH (P=0.024; Figure 5 ).
Discussion
The diagnostic functions of implanted pacemakers are a useful and reliable means of ATA detection in clinical practice. The yearly incidence of symptomatic or asymptomatic paroxysmal ATA diagnosed by pacemakers may reach 51%. 1-6 In the ASSERT trial, ATA lasting >6 min at a rate >190 beats/min were detected by the pacemaker in 36% of patients suffering from hypertension and who had no history of ATA. 1, 2 In that study, the risk of stroke among patients with device-detected ATA and a CHADS2 score ≥2 was similar to the risk incurred by patients presenting with atrial fibrillation and indications for oral anticoagulation. It is also noteworthy that, among pacemaker recipients without history of ATA, 35% of all cases of stroke or systemic embolism were preceded by ATA detected by the pacemaker. 1 However, to collect accurate diagnostic information, special attention must be paid to the device settings, including the post-ventricular atrial blanking period, atrial sensitivity and FFRW sensing. FFRW sensing is divided into 2 types: sensed by atrial channel after ventricular excitation (type 1) and before sensing the near-field signals of ventricular channel (type 2). 22 The former is more popular in clinical practice. Preventing FFRW sensing by the atrial channel after ventricular pacing is one of the greatest clinical challenges, as it inversely correlates with the duration of the post-ventricular atrial blanking period and with the atrial sensitivity.
In previous studies, the implantation of bipolar atrial leads with 1.1-mm instead of 10.0-mm spacing of the ring-tip electrodes lowered the risk of FFRW sensing in the RAA. 8,23-25 This observation had not been confirmed for the LAS region. In the present study, we found that (1) FFRW sensing in the LAS region was more prevalent than previously reported in the RAA, (2) the prevalence of FFRW signals at a sensitivity >0.3 mV was significantly lowered by the implantation of bipolar atrial leads with narrow tip-ring interelectrode spacing, and (3) the presence of LVH on 12-lead ECG, and the use of bipolar atrial leads with a wide tip-ring interelectrode spacing were both independent predictors of FFRW sensing in the LAS region.
Prevalence of FFRW in the LAS and RAA LAS pacing has been recommended as a means of preventing ATA in selected patients. 16,17 Depolarization spreads from the LAS to both atria nearly simultaneously, 15,16 shortening the P wave on the surface ECG and decreasing the dispersion of atrial refractoriness. Padelleti et al observed a significant decrease in the incidence of paroxysmal ATA by pacing the LAS as opposed to the RAA, 16 and found LAS pacing relatively straightforward. The overall prevalence of FFRW sensing after ventricular pacing in the RAA region, including 10.0-mm and 1.1-mm interelectrode spacing of the atrial elec- Programmed atrial sensitivity (mV) Prevalence of FFRW sensing (%) Figure 5 . Prevalence of far-field Rwave (FFRW) sensing at various atrial sensitivity settings in patients with or without left ventricular hypertrophy (LVH) on ECG (see text for detailed explanation). FFRW in LAS Pacing trodes, has been observed in up to 39% of patients with the atrial sensitivity set at 0.1 mV, and in up to 15% of patients with the sensitivity set at 0.3 mV. 23-25 In our study, FFRW after ventricular pacing was sensed in the LAS region in 77% and 29% of patients with the atrial sensitivity set at 0.1 and 0.3 mV, respectively. This difference may be explained by the closer proximity of the LAS to the ventricular muscle compared with the RAA. 18 Effects of the Spacing of the Tip-Ring Electrode of the Bipolar Atrial Lead on FFRW Sensing in the LAS The interelectrode spacing of bipolar atrial leads determines, in part, the likelihood of FFRW sensing, 8,23-25 which tends to decrease as the spacing narrows. [23] [24] [25] In the RAA, at a sensitivity of 0.3 mV, FFRW were sensed in 30% of recipients of leads with 10-mm interelectrode spacing, and in none of the patients who received leads with ring-tip electrodes separated by 1.1 mm. 23, 24 The capture and sensing thresholds of these leads were similar and remained stable in the long term. [23] [24] [25] In our study, the prevalence of sensed FFRW in the LAS region at an atrial sensitivity ≥0.3 mV was significantly higher when the ring-tip electrodes spacing was 10.0 mm than when it was 1.1 mm, while the pacing and sensing thresholds were similar. Thus, a shorter interelectrode spacing of the atrial lead lowered the likelihood of sensed FFRW, without interfering with pacing. In addition, the amplitude of FFRW sensing after ventricular pacing in the LAS was significantly higher than that after ventricular sensing in both 10.0-mm and 1.1-mm spacing leads. This result suggests that the amplitude of FFRW sensing after ventricular pacing is generally higher than that after ventricular sensing in both the RAA and LAS.
Correlation Between LVH and FFRW Sensing in the LAS
The prevalence and characteristics of FFRW sensing are influenced by the atrial lead position, 18,26 although the higher prevalence of FFRW sensing in the LAS than in the RAA remains unexplained. 18 One putative explanation is the shorter distance between the ventricular muscle and the atrial lead when the latter is in the LAS than when it is in the RAA. Another tentative explanation is the effect exerted by the electrical activity of the ventricular myocardium on the prevalence and amplitude of sensed FFRW, particularly in the LAS region, reflected by the QRS voltage on the 12-lead ECG. Therefore, we examined the relationship between the prevalence and amplitude of sensed FFRW and presence of LVH on the ECG, and found the latter to be an independent predictor of FFRW sensing.
Clinical Implications and Study Limitations
The benefit of implanting the atrial lead in the LAS site, other than the preventive effect on atrial fibrillation, is thought to be as follows. First, LAS pacing will shorten the AV interval (ApVs) in sinus node disease patients with preserved AV conduction or the presence of mild AV conduction disturbance, compared with RAA pacing. 27 This may result in a reduction in the cumulative % of ventricular pacing (cum% Vp), because the increase in cum% Vp induces LV dyssynchrony and heart failure in the long term. 28 Second, high pacing/sensing thresholds of the RAA are not rare in sinus node disease patients, especially in brady-tachy syndrome or atrial standstill, because of the extension of disease from the sinus node to atrial muscle in these patients. However, the pacing/sensing thresholds of LAS site are commonly preserved and acceptable in these patients.
In the present study, we did not measure the prevalence of sensed FFRW after sensed ventricular events. However, FFRW sensing is notoriously more likely after paced than after sensed R waves. 9,10 Furthermore, intrinsic AV conduction was not observed after pacemaker implantation in 7 patients. Second, the amplitude of the FFRW signals and the time interval between the ventricular pacing stimulus and sensing of FFRW in the atrium may vary with different body positions, and we made all the measurements with the patients in the supine position. However, Cools et al found that supine measurements were generally sufficient to predict the presence vs. absence of FFRW sensing at rest or at peak exercise. 10 Third, the prevalence and characteristics of FFRW were studied 7 days after pacemaker implantation and we did not examine the long-term evolution of the amplitude of sensed FFRW. However, in the study by Fung et al, the amplitude of FFRW at 90 days and at 1 year of follow-up was similar. 23 Finally, it is still obscure whether sensing during atrial fibrillation, using 1.1-mm short tip-ring electrode distance, is acceptable or not, compared with the standard 10-mm tip-ring electrode distance. Further studies are needed.
Conclusions
FFRW sensing in the LAS was common in the present study. The use of narrow-spaced tip-ring electrodes of the atrial lead is recommended when it is implanted in the LAS, particularly in the presence of LVH on the ECG.
